No Data
No Data
AbbVie Says Latest FDA Approval Expands Botox Use Beyond Face
Market Whales and Their Recent Bets on VRTX Options
Alnylam Canada Signs LOI From Pan-Canadian Pharmaceutical Alliance For The Public Reimbursement Of AMVUTTRA For The Treatment Of Hereditary Transthyretin-Mediated Amyloidosis In Adults
Here's How Much $100 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
Vertex Coverage Resumed by UBS at Buy on Growth Potential
Market Analysis: AbbVie And Competitors In Biotechnology Industry